Login
$CMMB
$1.00 -$0.03 (2.91%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
ASSETS
Current assets
Cash and cash equivalents
Short-term bank deposit
Restricted cash
Other receivables and prepaid expenses
Total current assets
Non-current assets
Long-term prepaid expenses
Restricted cash
Property and equipment, net
Operating lease right-of-use assets
Total non-current assets
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Trade payables
Due to related parties
Employees and related expenses
Operating lease liabilities
Total current liabilities
Non-current liabilities
Non-current operating lease liabilities
Total non-current liabilities
Total liabilities
Shareholders' equity
Ordinary Shares no par value - Authorized: 4,650,000,000 as of December 31, 2025, and December 31, 2024. Issued and outstanding: 575,381,320, and 377,132,220 Ordinary shares of December 31, 2025 and 2024, respectively (*)
Treasury share at cost (11,640,460 shares as of December 31, 2022)
Additional paid-in capital
Accumulated deficit
Total shareholders' equity
Total liabilities and shareholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support